| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enanta Pharmaceuticals Inc (ENTA) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 31 sells. ENTA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.0K | $13.16M | - | |
| Other | 371.4K | $5.70M | - | |
| Other | 38.3K | $588.0K | - | |
| Other | 30.6K | $469.7K | - | |
| Other | 21.8K | $334.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | Luly Jay R.71 | President And CEO | Sale+OE | 30,000 | $44.72 | $1,341,712.85 | -1.3% | -4.3% | -79.4% | |
| Apr 4, 2022 | Adda Nathalie80 | Sr. VP &Chief Medical Officer | Sale+OE | 83,344 | $71.60 | $5,967,688.19 | -21.5% | -28.7% | -47.4% | |
| Mar 21, 2022 | Carter Bruce L A | Director | Sale+OE | 6,000 | $67.83 | $406,970.05 | -45.6% | -39.4% | -38.5% | |
| Mar 2, 2022 | Adda Nathalie80 | Sr. VP &Chief Medical Officer | Sale+OE | 36,820 | $70.20 | $2,584,681.81 | -26.0% | -42.8% | -31.7% | |
| Jan 11, 2022 | Adda Nathalie80 | Sr. VP &Chief Medical Officer | Sale+OE | 12,536 | $70.13 | $879,149.68 | -27.6% | +4.1% | -28.4% | |
| Dec 1, 2021 | Adda Nathalie80 | Sr. VP &Chief Medical Officer | Sale+OE | 13,523 | $86.35 | $1,167,689.95 | -5.0% | -17.2% | -47.0% | |
| Nov 1, 2021 | Adda Nathalie80 | Sr. VP &Chief Medical Officer | Sale+OE | 9,547 | $84.89 | $810,419.02 | -9.7% | -30.1% | -46.8% | |
| Oct 11, 2021 | Adda Nathalie80 | Sr. VP &Chief Medical Officer | Sale+OE | 17,500 | $70.15 | $1,227,619.63 | -24.5% | -0.3% | -33.4% | |
| Sep 15, 2021 | Luly Jay R.71 | President And CEO | Sell | 4,516 | $59.06 | $266,697.80 | -0.7% | +18.5% | -1.2% | |
| Jan 8, 2021 | Mellett Paul J63 | Treasurer And CFO | Sell | 6,000 | $45.58 | $273,462.60 | -8.9% | - | - |